Literature DB >> 21293071

Gene silencing of Tead3 abrogates radiation-induced adaptive response in cultured mouse limb bud cells.

Guillaume Vares1, Bing Wang, Kaoru Tanaka, Yi Shang, Keiko Taki, Tetsuo Nakajima, Mitsuru Nenoi.   

Abstract

There is a crucial need to better understand the effects of low-doses of ionizing radiation in fetal models. Radiation-induced adaptive response (AR) was described in mouse embryos pre-exposed in utero to low-doses of X-rays, which exhibited lower apoptotic levels in the limb bud. We previously described AR-specific gene modulations in the mouse embryo. In this study, we evaluated the role of three candidate genes in the apoptotic AR in a micromass culture of limb bud cells: Csf1, Cacna1a and Tead3. Gene silencing of these three genes abrogated AR. Knowing that TEAD3 protein levels are significantly higher in adapted cells and that YAP/TAZ/TEAD are involved in the control of cell proliferation and apoptosis, we suggest that modulation of Tead3 could play a role in the induction of AR in our model, seen as a reduction of radiation-induced apoptosis and a stimulation of proliferation and differentiation in limb bud cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293071     DOI: 10.1269/jrr.10101

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  2 in total

1.  TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression.

Authors:  Qun Zhang; Hang Fan; Qian Zou; Hongda Liu; Bing Wan; Suhua Zhu; Yangbo Hu; Huijuan Li; ChenXi Zhang; Li Zhou; Qingqing Zhu; Kunhong Xiao; Jianya Zhang; Ping Zhan; Tangfeng Lv; Yong Song
Journal:  J Cell Mol Med       Date:  2018-04-18       Impact factor: 5.310

2.  The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in Chinese hepatocellular carcinoma patients.

Authors:  Haiyan Xia; Juan Wen; Weiyong Zhao; Dongying Gu; Zhibin Hu; Jinfei Chen; Zhi Xu
Journal:  Oncotarget       Date:  2017-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.